First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133

Abroad (travel likely)RecruitingPHASE1

Conditions

Staphylococcus Aureus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Dermatology, University Hospital Tuebingen, Tübingen, Germany
Contact: Study coordinator (Dr. Volc) · sebastian.volc@med.uni-tuebingen.de · +49 (0) 7071 29-83471
Contact: Principal Investigator (Dr Volc)
Department of Dermatology, Tübingen, Germany
Contact: Study coordinator (Dr. Volc) · sebastian.volc@med.uni-tuebingen.de · +49 (0) 7071 29-83471

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults

Staphylococcus Aureus Bloodstream Infection

Abroad (travel likely)RecruitingPHASE1

Sumida-ku, Japan

Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome

Staphylococcus Aureus · Microbial Colonization · Neonatal Infection

Abroad (travel likely)RecruitingPHASE1

Baltimore, United States

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Staphylococcus Aureus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Huntsville, United States · Chula Vista, United States

Linezolid Plus Standard of Care

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)

Abroad (travel likely)Recruiting

Aarau, Switzerland · Basel, Switzerland